CHRIS LEE

Senior Vice President and President, Greater China
surgery
Medtronic New Zealand Limited
New Zealand

Business Expert Surgery
Biography

 Chris Lee (李希烈) is the Senior Vice President and President of Medtronic Greater China and serves as a member of the Medtronic Executive Committee. In this role, he assumes management responsibility and oversees daily operations in Medtronic’s Greater China offices. Chris joined Medtronic on September 3, 2012 from Bayer HealthCare, where he had most recently served as Region Head for China and Hong Kong/Managing Director. In the role at Bayer HealthCare, Chris was responsible for overall Bayer Healthcare operations in China and Hong Kong with annual sales in excess of $1.7 billion and more than 6,000 staff, including responsibility for pharmaceuticals, consumer over the counter, animal health and medical devices. Chris has a long track record of strong global leadership in healthcare. Before Bayer, he had worked with a number of multinational companies like Bristol Myers Squibb in Asia Pacific, including Korea, Australia and New Zealand, as well as multinational companies operating in the U.S., such as Merch Sharp and Dohme. Over the past years, Chris has won a variety of awards issued by the Chinese government, national media, and industry associations, for his outstanding business leadership and contribution to the development of Chinese healthcare sector. He is the author of two best-selling books, one on emotional management and the other on marketing. He is also a pioneer in workplace happiness management. Chris holds a bachelor's degree from the University of Arizona, Tucson and a master’s degree from the American Graduate School of International Management (Thunderbird). He is fluent in English and Korean, with good understanding of Mandarin Chinese and Japanese. Chris has presented at a number of prestigious institutions on the topics of management and leadership. He once served as an executive director in pharmaceutical industry associations in China (RDPAC), Australia (Medicines Australia), and Korea (Korea Pharma).

Research Intrest

 surgery